PELONews

PELONews: New Supplier THT Biomaterials

THT Biomaterials offers a suite of fully human, animal-component-free extracellular matrix coatings and substrates tailored for advanced cell culture and tissue engineering.

PELOPaper: A 3D ex vivo model in childhood acute lymphoblastic leukemia

Kanari et al. (2025)aD bone marrow mimicco-culturing childhood ALL patient derived leukemic cells with human mesenchymal stromal cells...

PELOThink: Adult vs. Mesenchymal stem cells? What are the differences

PELONews, General, PELOPaper

PELONews: Holiday Shipping Schedule

Holiday Shipping Schedule 2025. The festive season is coming up! To help make sure your orders arrive on time, please take note of our holiday shipping dates below:

PELOPaper: Tiny defects, big impact: How cells organize into living tissues

Ever wondered how cells self-organize into the beautifully ordered tissues of our bodies? Our latest study shows that tiny “topological defects” in endothelial monolayers play a surprisingly critical role in shaping living tissue structure.

New Product | Mag-Net HP™ Kit: Unleashing the Hidden 98% of the Plasma Proteome

In plasma proteomics, the proteins that matter most are often the hardest to see. With concentrations spanning >10 orders of magnitude, abundant carriers such as albumin routinely drown out low-abundance biomarkers linked to neuro­degeneration, cancer, and metabolic disease.

Advancing Blood-Brain Barrier (BBB) Research: Tools and Insights from PELOBiotech

PELOBiotech offers a comprehensive range of solutions for BBB research, including high-quality primary cells, growth media, and advanced platforms like midifluidic systems and 3D hydrogels.

PELOPaper: Blood-Brain Barrier Disruption in Autoimmune Encephalitis

A recent dissertation from Charité Universitätsmedizin Berlin by Lucie Yuanting Li explores the role of autoantibodies in autoimmune encephalitis, provides insights into mechanisms that disrupt the blood-brain barrier (BBB).

Meet us at...IGLD Symposium 2025 In Frankfurt

PELOBiotech is attending, IGLD symposium from 07 - 09 March 2025 , in Frankfurt. Join us and meet our CEO Dr. Peter Frost, our Marketing head Christiane B chsel and Sales Representative Magdalena Meier at the booth. Also you can schedule face-to-face interaction with our CEO Dr. Peter Frost and team.

Meet us at... Elrig Forum 2025 in Darmstadt

PELOBiotech is attending The ELRIG Forum on March 13, 2025 at the Science and Congress center "darmstadtium" in Darmstadt. Schedule your on-site meeting with our CEO Dr. Peter Frost , at our booth.

PELOPaper: Insights into Infant Formula and Immune Responses

A recent study published in the European Journal of Nutrition by Hedegger, Hommel, Schaubeck et al. explores the impact of different infant formulas on intestinal immune responses.

PELOPaper: Advanced Skin Research with a Psoriasis Skin Equivalent Model

A recent study introduces a bilayered skin equivalent that closely mimics psoriasis. This innovative model bridges a critical gap in preclinical studies, offering unparalleled insights into disease mechanisms and potential therapeutic interventions.